ET gets HIT - Thrombocytotic heparin-induced thrombocytopenia (HIT) in a patient with essential thrombocythemia (ET)

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 7, 2000, Pages 663-667

  Risch, L ^a   Pihan, H ^b   Zeller, C ^b   Huber, Andreas R ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b NONE   (Switzerland)

Author keywords

Essential thrombocythemia; Heparin; Hirudin; Intracranial embolism and thrombosis; Thrombocythemia; Thrombocytopenia; Thrombocytosis; Thrombosis; Transie nt ischemic attack; Treatment outcome

Indexed keywords

HEPARIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INDUCED DISEASE; ENDARTERECTOMY; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOPENIA; THROMBOCYTOSIS; THROMBOEMBOLISM;

HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOCYTOPENIA;

EID: 0033756571     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200010000-00011     Document Type: Article

References (23)

1. Heparin-induced thrombocytopenia: Towards consensus
2. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia
3. Presence of autantibodies to interleukin-8 or neutrophil-activating peptide in patients with heparin-associated thrombocytopenia
4. Clinical presentation of heparin-induced thrombocytopenia
5. Heparin-associated thrombosis without thrombocytopenia
6. Heparin-associated thrombosis despite normal platelet counts
7. Heparin-induced platelet activation in sixteen surgical patients: Diagnosis and management
8. Thrombosis in patients with heparin-induced thrombocytopenia
9. Heparin as a cause of tumor progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts
10. Heparin-related thrombosis despite normal platelet counts in vascular surgery
11. Heparin-induced thrombocytopenia: A spectrum of hemorhage and thrombosiscase presentations
12. Heparin-induced thrombocytopenia: A ten-year retrospective
13. Laboratory tests for of heparin-induced thrombocytopenia: A multicenter study
14. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-associated thrombocytopenia study (HAT) investigators
15. Treatment of essential thrombocythemia with anagrelide
16. Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin-associated thrombocytopenia
17. The incidence and epidemiology of essential thrombocythemia and agnogemc myeloid metaplasia: An Olmsted county study
18. Heparin-induced thrombocytopenia in patients treated with low-molecularweight heparin or unfractionated heparin
19. A 14-year study of heparin-induced thrombocytopenia
20. Comparison of two PF4/ heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia
21. Comparison of PF4/heparin ELISA assay with the 14C serotonin release assay in diagnosis of heparin-induced thrombocytopenia
22. Neurological complications in heparin-induced thrombocytopenia
23. Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution